HomeAI · summaries
Storia in 7 fonti
What's Going on With AstraZeneca Stock Monday? - AstraZeneca (NYSE:AZN)
AstraZeneca (AZN) Q2 2026: EPS beats estimates at $2.63 despite missing revenue targets. Oncology sales up 16%. Get the full recap.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
hurriyetdailynews.com
AstraZeneca quarterly net profit rises on strong cancer drug sales - Latest News
British pharmaceutical giant AstraZeneca yesterday said net profit rose in its second quarter, driven once again by strong growth in sales of its cancer drugs.
- ·
independent.co.uk
AstraZeneca sales rise as demand for cancer treatments grow
It reported total revenues of 30.67 billion US dollars for the first six months of 2026.
